HiberCell, Inc.

This company is dedicated to the development of therapies that target vulnerabilities driven by adaptive stress. Their primary focus is on combating treatment resistance, cancer relapse, and metastasis. Their innovative approach to cancer treatment sets them apart in the field of oncology.